Stockscreener 앱 받기
0.1401
0.92%
-0.0013
전일 마감가:
$0.1414
열려 있는:
$0.1366
하루 거래량:
249.16K
Relative Volume:
0.20
시가총액:
$1.55M
수익:
순이익/손실:
주가수익비율:
-
EPS:
-
순현금흐름:
1주 성능:
-12.38%
1개월 성능:
-40.61%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$0.00
$0.00
1주일 범위
$0.1344
$0.16
52주 변동 폭
$0.1367
$0.4599
Endovia Health Sciences, Inc. Stock (EDVA) Company Profile
Compare EDVA vs VRTX, MRNA, REGN, ARGX, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EDVA
Endovia Health Sciences, Inc.
|
0.1401 | 1.55M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
508.75 | 128.95B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
236.50 | 94.42B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
796.34 | 81.99B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
846.27 | 53.22B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
374.08 | 42.32B | 5.76B | 514.49M | 1.10B | 4.4813 |
Endovia Health Sciences, Inc. 주식(EDVA)의 최신 뉴스
Endovia Health Sciences Announces FDA Minor Use Determination for CannEpil® in Dogs With Bone Cancer Pain - Quiver Quantitative
A proposed treatment for dogs’ bone cancer pain qualifies to pursue conditional FDA approval - Stock Titan
Endovia Health Sciences Enters Letter Agreement With C/M Capital Master Fund On Sept 18, 2026 - TradingView
Endovia Health Sciences Secures $1 Million Investment Commitment for CannEpil Development - Minichart
Endovia Health Sciences Secures $510,000 Convertible Note From C/M Capital, Part of $1 Million Commitment - TradingView
Endovia secures $1M minimum investment commitment - Stock Titan
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Nigeria
Form PRE 14A ENDOVIA HEALTH SCIENCES For: 24 September By Investing.com - Investing.com Canada
Endovia Health Sciences (EVDA) Stock Soars 48% After-Hours: Here's What's Going On - Benzinga
Endovia Health Sciences Secures Initial Funding to Advance CannEpil Development - citybiz
Endovia Health Sciences Announces Closing of Initial Funding Tranche to Advance CannEpil® Development and Commercialization - Quiver Quantitative
A proposed law could give qualifying botanical drugs 12 years of market exclusivity. Endovia closes funding. - Stock Titan
EDVA PE Ratio & Valuation, Is EDVA Overvalued - Intellectia AI
EDVA Technical Analysis & Stock Price Forecast - Intellectia AI
EDVA Should I Buy - Intellectia AI
EDVA Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Splash Beverage H1 loss narrows 64%, rebrands as Endovia Health Sciences - scanx.trade
Endovia Health Sciences Welcomes Historic Shift in Federal - GlobeNewswire
Endovia Health Sciences Welcomes Historic Shift in Federal Cannabinoid Policy; Advances CannEpil® FDA Submission and Expands Development Pipeline - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves First FDA Regulatory Milestone for CannEpil® Veterinary Development Program - Yahoo Finance
Endovia Health Sciences, formerly Splash Beverage, Achieves - GlobeNewswire
Endovia's potential cannabinoid treatment for dogs with cancer pain enters FDA process - Stock Titan
EDVA Stock Quote Price and Forecast - CNN
Endovia Health Sciences, Inc. Balance Sheet – AMEX:EDVA - TradingView
Discontinued operations of Endovia Health Sciences, Inc. – AMEX:EDVA - TradingView
Endovia Health Sciences, Inc. Financial Statements – AMEX:EDVA - TradingView
EDVA Stock Price and Chart — AMEX:EDVA - TradingView
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - Yahoo Finance
Splash Beverage Group to Become Endovia Health Sciences; New NYSE American Ticker “EDVA” Effective Monday - GlobeNewswire
Splash Beverage Reports Second Quarter 2026 Results and - GlobeNewswire
Splash Beverage Group Reports Q2 2026 Results and Advances Transformation to Endovia Health Sciences - Quiver Quantitative
Splash Beverage shifts from alcoholic drinks to cannabinoid medicines for people and pets - stocktitan.net
Splash Beverage to rebrand as Endovia Health Sciences By Investing.com - Investing.com UK
Splash Beverage Group to Rebrand as Endovia Health Sciences - GlobeNewswire
Splash Beverage will officially become Endovia Health Sciences on August 21 (SBEV:NYSE) - Seeking Alpha
Splash Beverage to rebrand as Endovia Health Sciences - Investing.com
Splash Beverage Group to Rebrand as Endovia Health Sciences - Yahoo Finance UK
Splash Beverage to Rebrand as Endovia Health Sciences - Yahoo Finance
Splash Beverage plans shift from beverage business to cannabinoid health sciences - Stock Titan
Splash Beverage Group Announces Significant Balance Sheet - GlobeNewswire
Splash Beverage Group Receives NYSE American Acceptance of - GlobeNewswire
SBEV Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Endovia Health Sciences, Inc. (EDVA) 재무 분석
Endovia Health Sciences, Inc. (EDVA)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
1.35%
자본화:
|
볼륨(24시간):